Exscientia (NASDAQ:EXAI – Get Free Report) and Repligen (NASDAQ:RGEN – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership. Analyst Recommendations This is a summary of recent recommendations and […]
Exscientia (NASDAQ:EXAI – Get Free Report) and Bio-Techne (NASDAQ:TECH – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Risk & Volatility Exscientia has a beta of 0.47, indicating […]
Shares of Exscientia plc (NASDAQ:EXAI – Free Report) dropped 5.3% during mid-day trading on Thursday . The stock traded as low as $5.62 and last traded at $5.68. Approximately 134,802 shares traded hands during trading, a decline of 59% from the average daily volume of 332,101 shares. The stock had previously closed at $6.00. Analysts […]
Exscientia plc (NASDAQ:EXAI – Get Rating)’s share price traded down 5.9% during mid-day trading on Wednesday . The company traded as low as $7.72 and last traded at $7.81. 38,125 shares were traded during mid-day trading, a decline of 89% from the average session volume of 333,460 shares. The stock had previously closed at $8.30. […]
Exscientia plc (NASDAQ:EXAI – Get Rating) saw a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 1,380,000 shares, a growth of 5.3% from the April 30th total of 1,310,000 shares. Currently, 1.2% of the company’s stock are sold short. Based on an average daily […]